GR-MD-02
GT-020
Phase 1 small_molecule completed
Quick answer
GR-MD-02 for Non-Alcoholic Steatohepatitis (NASH) is a Phase 1 program (small_molecule) at GALECTIN THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GALECTIN THERAPEUTICS INC
- Indication
- Non-Alcoholic Steatohepatitis (NASH)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed